SynsoryBio
Active"If-then" conditional logic for protein drugs
About
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
Founders
Elliot Tague· FounderI am a PhD and inventor in the fields of synthetic biology and protein engineering. I got my PhD from Boston University, spent time as a visiting graduate student in George Church's lab at Harvard, and worked in various biotech startups
Nathan Tague· FounderI’m a co-founder of SynsoryBio, where we are creating therapeutics that sense-and-respond to disease. I have a background in synthetic biology and protein engineering with a PhD in Biomedical Engineering.
Product launches · 1 launch
Our immune system acts locally to combat disease, why don’t our medicines?
Change history · 6 recorded
- July 12, 2026
- Founder profile updated08:01 PM
- Launches refreshed08:01 PM
- June 28, 2026
- Launches refreshed08:00 PM
- Founder profile updated08:00 PM
- June 14, 2026
- Founder profile updated08:01 PM
- Launches refreshed08:01 PM